FRAMINGHAM, Mass. FRAMINGHAM, Mass.--(BUSINESS WIRE)--Solace Therapeutics, Inc., today announced the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback